4//SEC Filing
Oakes Gregory 4
Accession 0001209191-22-038682
CIK 0001785345other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:28 PM ET
Size
5.5 KB
Accession
0001209191-22-038682
Insider Transaction Report
Form 4
Oakes Gregory
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-06-20+1,677,251→ 1,677,251 totalExercise: $0.79Exp: 2032-06-19→ Common Stock (1,677,251 underlying)
Footnotes (1)
- [F1]25% of the shares of common stock underlying this option will vest and become exercisable on June 20, 2023 and the remaining shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001809796
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:28 PM ET
- Size
- 5.5 KB